Developed by Shray Alag, The Harker School
Sections: Correlations,
Clinical Trials, and HPO
Navigate: Clinical Trials and HPO
| Name (Synonyms) | Correlation | |
|---|---|---|
| drug1502 | Face-to-face medical visits Wiki | 1.00 |
| drug262 | Alternating face-to-face medical visits and video medical consultations Wiki | 1.00 |
| Name (Synonyms) | Correlation | |
|---|---|---|
| D001172 | Arthritis, Rheumatoid NIH | 0.27 |
| D001168 | Arthritis NIH | 0.23 |
| Name (Synonyms) | Correlation | |
|---|---|---|
| HP:0001370 | Rheumatoid arthritis HPO | 0.27 |
| HP:0001369 | Arthritis HPO | 0.23 |
Navigate: Correlations HPO
There is one clinical trial.
This study will provide investigational convalescent plasma for patients infected with the SARS-CoV-2 with mild to moderate symptoms who meet inclusion criteria as judged by physician evaluation.
Description: a. Time to resolution of symptoms will be defined as time from randomization (day 0) to a successful outcome. c. A successful outcome is defined as symptom improvement of 3 numbers or down to zero on the memory aid for all symptoms noted.
Measure: Time to Resolution of Symptoms Time: 28 daysDescription: A 50% decrease at day 28 in C-Reactive Protein (mg/mL)
Measure: Decrease in Inflammatory Markers Time: 28 daysDescription: A 50% decrease at day 28 in D-Dimer (ng/mL)
Measure: Decrease in Inflammatory Markers Time: 28 daysDescription: A 50% decrease at day 28 in Ferritin (ng/mL)
Measure: Decrease in Inflammatory Markers Time: 28 daysDescription: A 50% decrease at day 28 in Lactate Dehydrogenase (U/L)
Measure: Decrease in Inflammatory Markers Time: 28 daysAlphabetical listing of all HPO terms. Navigate: Correlations Clinical Trials
Data processed on September 26, 2020.
An HTML report was created for each of the unique drugs, MeSH, and HPO terms associated with COVID-19 clinical trials. Each report contains a list of either the drug, the MeSH terms, or the HPO terms. All of the terms in a category are displayed on the left-hand side of the report to enable easy navigation, and the reports contain a list of correlated drugs, MeSH, and HPO terms. Further, all reports contain the details of the clinical trials in which the term is referenced. Every clinical trial report shows the mapped HPO and MeSH terms, which are also hyperlinked. Related HPO terms, with their associated genes, protein mutations, and SNPs are also referenced in the report.
Drug Reports MeSH Reports HPO Reports